Clinical Trial Update: Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

The Phase 1 trial evaluating safety, tolerability, and preliminary efficacy in advanced or metastatic breast cancer has been terminated. Sponsor: Kyowa Kirin Co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Breast Cancer | Phase 1 | Status: TERMINATED